News
A new collaboration between Apertura and the National Institutes of Health (NIH) aims to advance a potential gene therapy for Niemann-Pick Disease Type C1 (NPC1), a rare and often fatal neurodegenerative disorder. Under a newly signed Cooperative Research and Development Agreement (CRADA), NIH and
Louis Staudt, M.D., Ph.D. was recently awarded the Career Achievement Award, which recognizes ten or more years in HHS and dedication and loyalty to the Department. Dr. Staudt is the Chief of the Lymphoid Malignancies Branch at NCI. Dr. Staudt pioneered the use of gene expression profiling to
Register for your spot at the National Cancer Institute (NCI) and Frederick National Lab (FNL) 2021 Technology Showcase. This event provides potential partners the opportunity to attend presentations on federal technologies ready for commercialization and/or collaboration, watch panel sessions
Two NIH Intramural Inventors have received an HHS departmental award. Steven Rosenberg, M.D., Ph.D. was awarded the Secretary’s Award for Distinguished Service. This is the highest honor given by HHS. Dr. Rosenberg is the Chief of Surgery Branch at the National Cancer Institute (NCI). The award he